Navigation Links
Novavax Reports First Quarter 2008 Financial Results
Date:5/9/2008

ROCKVILLE, Md., May 9 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced financial results for the first quarter 2008. Novavax reported a net loss of $7.8 million ($0.13 loss per share) for the first quarter of 2008 compared to a net loss of $8.4 million ($0.14 loss per share) for the first quarter of 2007. Total cash and short-term investments as of March 31, 2008 were $40.9 million compared to $46.5 million as of December 31, 2007. The cash burn for the quarter was $5.6 million.

The following are key achievements during the quarter as well as additional plans for the balance of the year:

-- Commenced Phase IIa clinical studies for its H5N1 pandemic influenza

vaccine as a continuation of the original Phase I/IIa trial which

started last year. An interim analysis in December 2007 was favorable,

indicating that this vaccine demonstrated immunogenicity at 15

microgram and 45 microgram dose levels and was well tolerated. The

Company remains on plan to report preliminary immunogenicity results

from the dose-ranging portion of this Phase IIa study in late third

quarter/early fourth quarter of 2008.

-- Continued as planned to advance its seasonal influenza vaccine program

through pre-clinical studies with a target of commencing human trials

in a Phase IIa study in early third quarter of 2008. The Company

believes the initial results from the pandemic influenza vaccine study

bode well for the seasonal program. It is important to note the safety

data generated in the ongoing Phase I/IIa H5N1 pandemic influenza study

will be used to support the safety database for our seasonal program

which will allow us to begin human trials for this program with a Phase

IIa trial.

-- Pending a successful outcome of the Phase IIa trial, an additional

Phase IIb trial of our seasonal infl
'/>"/>

SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Novavax CEO to Present at BIO CEO & Investor Conference
2. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
3. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
4. Novavax CEO to Present at the World Vaccine Congress 2008
5. Novavax Opens Its First U.S. Vaccine Plant
6. Novavax Announces Release Date of 2008 First Quarter Financial Results and Investor Conference Call
7. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
8. QMed, Inc. Reports July Medicare SNP Enrollments
9. Phlo Affiliate Reports Expanded Coverage to Oregon Border
10. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
11. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... (PRWEB) August 20, 2014 High ... and apply the most complete climate and Earth ... demanding climate change issues. , Eight national laboratories, ... with the National Center for Atmospheric Research, four ... new effort. Other participating national laboratories include Argonne, ...
(Date:8/20/2014)... Aug. 20, 2014 /PRNewswire-iReach/ -- A case study ... between the school,s bioengineering department and the Intel® ... Intel® Software Academic Program, UCSD,s research focuses on ... human body.  Photo - ... the work of Dr. Todd P. Coleman ...
(Date:8/19/2014)... Md. (PRWEB) August 19, 2014 ... liquid chromatography systems, Prominence-i and Nexera-i, adding to ... systems. Combining excellent functionality, an intuitive operating environment, ... and a more efficient workflow for conventional to ... feature innovative, intuitive and intelligent design so users ...
(Date:8/19/2014)... (PRWEB) August 19, 2014 Robin Williams’ ... disease can take on an individual. Symptoms range ... facial expression, problems swallowing and severe depression. Parkinson’s ... dying off of dopamine producing neurons of the brain. ... a disease that slowly and progressively gets worse, they ...
Breaking Biology Technology:New Project Is the ACME of Addressing Climate Change 2New Project Is the ACME of Addressing Climate Change 3Intel and University of San Diego Bioengineering Department Release Case Study on Health Sciences Research 2Shimadzu’s New i-Series Integrated Liquid Chromatography Systems Provide Laboratories Wider Range of Analytical Capabilities 2Shimadzu’s New i-Series Integrated Liquid Chromatography Systems Provide Laboratories Wider Range of Analytical Capabilities 3As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 2As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 3
... January 24 The European Commission has granted,marketing ... antidepressant for the treatment of adult patients,with major ... is still great scope for improved therapies to ... from Warneford,Hospital, Oxford, United Kingdom. "Valdoxan is an ...
... has launched www.EyeScience.com to fill a large ... macular degeneration (AMD) in a unique watch-and-learn video format. ... the leading cause of blindness in Americans age 50 ... basic eye anatomy, screening and diagnosis, risk factors, signs ...
... Feb. 24 /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, ... Company") (Nasdaq: CSKI ), a,leading ... the People,s Republic of China ("PRC"), today ... Jin Chuang Pharmaceutical Company ("Jin,Chuang"), signed an ...
Cached Biology Technology:Valdoxan(R) Granted Marketing Authorisation for the Treatment of Major Depressive Episodes in Europe 2Valdoxan(R) Granted Marketing Authorisation for the Treatment of Major Depressive Episodes in Europe 3EyeScience Launches Comprehensive Online Resource Devoted to Age-Related Macular Degeneration Education and Prevention 2China Sky One Medical, Inc. Signs Exclusive Distribution Agreement with Shaanxi Buchang Group for Naftopidil Dispersible Tablets 2China Sky One Medical, Inc. Signs Exclusive Distribution Agreement with Shaanxi Buchang Group for Naftopidil Dispersible Tablets 3
(Date:8/20/2014)... -- Bay Area Lyme Foundation, which aims to make ... applauds new research published in an upcoming issue of ... Diseases . The findings show that ticks that ... the year, making the threat of Lyme disease year-round. ... of Public Health (CDPH) Vector-borne Disease Section and University ...
(Date:8/20/2014)... pepper causes a burning spiciness that is irresistible to ... pepper,s effect are using their findings to develop a ... can be caused by inflammation or other problems. They ... tested in clinical trials, in ACS, Journal of ... that decades ago, scientists had pegged a compound called ...
(Date:8/20/2014)... a colony of honeybees grows to about 4,000 members, ... cycle: the building of a special type of comb ... of experts from the Department of Neurobiology and Behaviour ... starts the reproductive cycle of honeybee colonies. The results ... Science of Nature . , Reproduction isn,t always ...
Breaking Biology News(10 mins):Lyme disease risk is year-round in Northwest California, according to new study 2Lyme disease risk is year-round in Northwest California, according to new study 3Worker bees 'know' when to invest in their reproductive future 2
... of frozen methane deposits is the likely cause of a ... years ago, according to an international research team led by ... finding is expected to come as a relief to scientists ... might have been touched off by methane melts in the ...
... individuals around the world are alive because of him. ... to make the use of life-saving devices such as ... and heart-lung bypass systems almost commonplace. In the ... biomaterials leader. John Brash, P.Eng., director of the ...
... in preparing for how data from the Sentinel-1 European ... land-cover mapping and crop management. Sentinel-1 is the first ... the GMES initiative. Sentinel-1 is a constellation of ... day and night imagery for use in a range ...
Cached Biology News:Wetlands likely source of methane from ancient warming event 2Wetlands likely source of methane from ancient warming event 3Canadian biomedical engineering pioneer receives international award 2A glimpse of future GMES Sentinel-1 radar images 2
... Ciphergen's ProteinChip arrays have been ... from biological samples. A variety of ... of proteins according to their unique ... different spots, allowing side-by-side sample comparison, ...
Freeze 'N Squeeze DNA gel extraction spin columns use a quick freeze-and-thaw cycle and centrifugation to draw 50-23,000 bp DNA out of agarose gel slices. Supplied as 25 columns....
The Freeze 'N Squeeze DNA gel extraction kit uses a quick freeze-and-thaw cycle and centrifugation to draw 50-23,000 bp DNA out of agarose gel slices. The kit includes materials for 100 preps....
The Sony UPD895 printer is used to print data captured with the Gel Doc XR and ChemiDoc XRS gel documentation systems as well as the VersaDoc imaging systems....
Biology Products: